Women's Health

Latest News


CME Content


Mylan Inc. today announced that it has, through its Indian subsidiary Mylan Laboratories Limited, signed a definitive agreement to acquire certain female health care businesses from Famy Care Limited, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs) for $750 million in cash plus additional contingent payments of up to $50 million.

While some researchers have associated human papillomavirus vaccination with an increased risk for multiple sclerosis, a new study found no such link between the vaccine and the development of demyelinating disease.